norm: arca biopharmaUSLEI 529900TG7O4ESUDMGI54 · no CIKMax severity: Low

Canonical registry

ARCA BIOPHARMA, INC.

ent_019e453736624205d0f307ee1a29b0fb

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: ARCA BIOPHARMA, INC.
Normalized: arca biopharma— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 529900TG7O4ESUDMGI54
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-02-01
ARCA biopharma's FY2023 Form 10-K Item 1C cybersecurity disclosure describes risk management processes, governance (CFO/COO oversight with IT consultant and audit committee), and third-party assessments. The Company explicitly states it has not encountered cybersecurity challenges that have materially impaired its operations or financial standing. No specific cybersecurity incident is disclosed.